Adverse childhood experiences (ACEs), genetic polymorphisms and neurochemical correlates in experimentation with psychotropic drugs among adolescents

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 8, 2011, Pages 1771-1778

  Somaini, L ^a   Donnini, C ^b   Manfredini, M ^b   Raggi, M A ^c   Saracino, M A ^c   Gerra, M L ^b   Amore, M ^b   Leonardi, C ^d   Serpelloni, G ^e   Gerra, G ^f  

^a Addiction Treatment Centre   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d ASL Roma B   (Italy)

^e Local Health Unit   (Italy)

^f United Nations Office on Drugs and Crime Austria   (Austria)

Author keywords

Adolescent; Adverse childhood experiences (ACEs); Substance abuse; Susceptibility

Indexed keywords

CORTICOTROPIN; DOPAMINE; DOPAMINE TRANSPORTER; HYDROCORTISONE; NEUROTRANSMITTER; PSYCHOTROPIC AGENT; SEROTONIN; SEROTONIN TRANSPORTER;

5 HTT GENE; ADOLESCENT; CHILD ABUSE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG DEPENDENCE; ENVIRONMENTAL FACTOR; FATHER CHILD RELATION; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOTHER CHILD RELATION; NEGLECT; NEUROCHEMISTRY; NEUROENDOCRINOLOGY; NEUROTRANSMISSION; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOTRAUMA; REVIEW;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; AGE FACTORS; CHILD; CHILD ABUSE; CHILD, PRESCHOOL; CRITICAL PERIOD (PSYCHOLOGY); HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROSECRETORY SYSTEMS; PITUITARY-ADRENAL SYSTEM; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; RESILIENCE, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 79960053945     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.11.008     Document Type: Review

References (104)

1. Aghajanian G.K. Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. Essays in Neurochemistry and Neuropharmacology 1978, vol. 3:1-33. Wiley and Sons, New York.
2. Anda R.F., Croft J.B., Felitti V.J. Adverse childhood experiences and smoking during adolescence and adulthood. JAMA 1999, 282:1652-1658.
3. Anda R.F., Felitti V.J., Douglas Bremner J., Walker J.D., Whitfield C., Perry B.D., Dube S.R., Giles W.H. The enduring effects of abuse and related adverse experiences in childhood - a convergence of evidence from neurobiology and epidemiology. Eur. Arch. Psychiatr. Clin. Neurosci. 2006, 256:174-186.
4. Barr C.L., Xu C., Kroft J., Feng Y., Wigg K., Zai G., Tannock R., Schachar R., Malone M., Roberts W., Nothen M.M., Grunhage F., Vandenbergh D.J., Uhl G., Sunohara G., King N., Kennedy J.L. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol. Psychiatr. 2001, 49:333-339.
5. Blier P., de Montigny C., Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J. Clin. Psychopharmacol. 1987, 7:24S-35S.
6. Blum K., Braverman E.R., Holder J.M., Lubar J.F., Monastra V.J., Miller D., Lubar J.O., Chen T.J., Comings D.E. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J. Psychoactive Drugs 2000, 32(Suppl. i-iv):1-112.
7. Brady K.T., Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am. J. Psychiatr. 2005, 162:1483-1493.
8. Breier A., Kelsoe J.R., Kirwin P.D., Beller S.A., Wolkowitz O.M., Pickar D. Early parental loss and development of adult psychopathology. Arch. Gen. Psychiatr. 1988, 45:987-993.
9. Bremner J.D. Long-term effects of childhood abuse on brain and neurobiology. Child Adolesc. Psychiatr. Clin. North Am. 2003, 12:271-292.
10. Cadoret R.J., Langbehn D., Caspers K., Troughton E.P., Yucuis R., Sandhu H.K., Philibert R. Associations of the serotonin transporter promoter polymorphism with aggressivity, attention deficit, and conduct disorder in an adoptee population. Compr. Psychiatr. 2003, 44:88-101.
11. Cappadocia M.C., Desrocher M., Pepler D., Schroeder J.H. Contextualizing the neurobiology of conduct disorder in an emotion dysregulation framework. Clin. Psychol. Rev. 2009, 29:506-518.
12. Castellanós F.X., Elia J., Kruesi M.J., Gulotta C.S., Mefford I.N., Potter W.Z., Ritchie G.F., Rapoport J.L. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiat. Res. 1994, 52:305-316.
13. Coccaro E.F., Kavoussi R.J., Sheline Y.I., Lish J.D., Csernansky J.G. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch. Gen. Psychiatr. 1996, 53:531-536.
14. Comings D.E., Wu S., Chiu C., Ring R.H., Gade R., Ahn C., MacMurray J.P., Dietz G., Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and DAT1. Am. J. Med. Genet. 1996, 67:264-288.
15. Cook E.H., Stein M.A., Ellison T., Unis A.S., Leventhal B.L. Attention deficit hypeactivity disorder and whole-blood serotonin levels: effects of comorbidity. Psychiat. Res. 1995, 57:13-20.
16. Costa P.T., MacCrae R.R. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five Factor Inventory (NEO-FFI) Professional Manual 1992, Psychological Assessment Resources, Odessa, FL.
17. Covault J., Tennen H., Armeli S., Conner T.S., Herman A.I., Cillessen A.H., Kranzler H.R. Interactive effects of the serotonin transporter 5-HTTLPR polymorphism and stressful life events on college student drinking and drug use. Biol. Psychiatr. 2007, 61:609-616.
18. Dube S.R., Anda R.F., Felitti V.J., Chapman D., Williamson D.F., Giles W.H. Childhood abuse, household dysfunction and risk of attempted suicide throughout life spain: findings from the adverse childhood experiences study. JAMA 2001, 286:3089-3096.
19. Dube S.R., Anda R.F., Felitti V.J., Edwards V.J., Croft J.B. Adverse childhood experiences and personal alcohol abuse as an adult. Addict. Behav. 2002, 27:713-725.
20. Duval F., Mokrani M.C., Monreal-Ortiz J.A., Fattah S., Champeval C., Schulz P., Macher J.P. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology 2006, 31:876-888.
21. Felitti V.J., Anda R.F., Nordenberg D. Realtionship of childhood abuse and household dysfunction to many of the leading causes of death in adults; the adverse childhood experiences (ACE) study. Am. J. Prev. Med. 1998, 14:245-258.
22. Flinn M.V. Are cortisol profiles a stable trait during child development?. Am. J. Hum. Biol. 2009, 21:769-771.
23. Galeeva A.R., Iur'ev E.B., Khusnutdinova E.K. The evaluation of VNTR-polymorphism in the gene of dopamine transporter in men of different nationalities with acute alcoholic psychosis. Zh. Nevropatol. Psikhiatr. Im. S S Korsakova 2001, 101:43-45.
24. Gelernter J., Kranzler H.R., Satel S.L., Rao P.A. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 1994, 11:195-200.
25. Gerra G., Fertonani G., Tagliavini P., Zaimovic A., Del signore R., Maestri D., Avanzino P., Caccavari R., Brambilla F. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge. Psychiatr. Res. 1995, 58:153-160.
26. Gerra G., Garofano L., Castaldini L., Rovetto F., Zaimovic A., Moi G., Bussandri M., Branchi B., Brambilla F., Friso G., Donnini C. Serotonin transporter promoter polymorphism genotype is associated with temperament, personality traits and illegal drugs use among adolescents. J. Neural Transm. 2005, 112:1397-1410.
27. Gerra G., Garofano L., Pellegrini C., Bosari S., Zaimovic A., Moi G., Avanzino P., Malarico E., Gardini F., Donnini C. Allelic association of a dopamine transporter gene polymorphism with antisocial behavior in heroin dependent patients: a preliminary explorative analysis. Addict. Biol. 2005, 10:275-281.
28. Gerra G., Garofano L., Santoro G., Bosari S., Pellegrini C., Zaimovic A., Moi G., Bussandri M., Moi A., Brambilla F., Donnini C. Association between low activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 2004, 126B:37-42.
29. Gerra G., Garofano L., Zaimovic A., Moi G., Branchi B., Bussandri M., Brambilla F., Donnini C. Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 2005, 135B:73-78.
30. Gerra G., Leonardi C., Cortese E., Zaimovic A., Dell'agnello G., Manfredini M., Somaini L., Petracca F., Caretti V., Raggi M.A., Donnini C. Childhood neglect and parental care perception in cocaine addicts: relation with psychiatric symptoms and biological correlates. Neurosci. Biobehav. Rev. 2009, 33:601-610.
31. Gerra G., Leopardi C., Cortese E., Zaimovic A., Dell'agnello G., Manfredini M., Somaini L., Petracca F., Caretti V., Saracino M.A., Raggi M.A., Donnini C. Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients. J. Neural Transm. 2007, 114:1637-1647.
32. Gerra G., Leopardi C., Cortese E., Zaimovic A., Dell'agnello G., Manfredini M., Somaini L., Petracca F., Caretti V., Baroni C., Raggi M.A., Donnini C. Adrenocorticotropic hormone and cortisol plasma levels directly correlate with childhood neglect and depression measures in addicted patients. Addict. Biol. 2008, 13:95-104.
33. Gerra G., Zaimovic A., Castaldini L., Garofano L., Manfredini M., Somaini L., Leonardi C., Gerra M.L., Donnini C. Relevance of perceived childhood neglect, 5-HTT gene variants and hypothalamus-pituitary-adrenal axis dysregulation to substance abuse susceptibility. J. Med. Genet. (Neuropsychiatr. Genet.) 2010, 153B:715-722.
34. Gerra G., Zaimovic A., Garofano L., Ciusa F., Moi G., Avanzino P., Malarico E., Gardini F., Brambilla F., Manfredini M., Donnini C. Perceived parenting behaviour in the childhood of cocaine users: relationship with genotype and personality traits. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 2007, 144B:52-57.
35. Gerra G., Zaimovic A., Zimbelli U., Del signore R., Baroni M.C., La viola G., Macchia T., Brambilla F. Neuroendocrine correlates of depression in abstinent heroin-dependent subjects. Psychiatry Res. 2000, 96(3):221-234.
36. Gorwood P., Limosin F., Batel P., Hamon M., Ades J., Boni C. The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol. Psychiatr. 2003, 53:85-92.
37. Gunnar M.R., Quevedo K. The neurobiology of stress and development. Annu. Rev. Psychol. 2007, 58:145-173.
38. Hagan M.J., Luecken L.J., Sandler I.N., Tien J.Y. Prospective effects of post-bereavement negative events on cortisol activity in parentally bereaved youth. Dev. Psychobiol. 2010, 52:394-400.
39. Hallikainen T., Saito T., Lachman H.M., Volavka J., Pohjalainen T., Ryynanen O.P., Kauhanen J., Syvalahti E., Hietala J., Tiihonen J. Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior. Mol. Psychiatr. 1999, 4:385-388.
40. Han D.H., Yoon S.J., Sung Y.H., Lee Y.S., Kee B.S., Lyoo I.K., Renshaw P.F., Cho S.C. A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence. Compr. Psychiatr. 2008, 49:387-392.
41. Hanna G.L., Yuwiler A., Coates J.K. Whole blood serotonin and disruptive behaviors in juvenile obsessive-compulsive disorder. J. Am. Acad. Child Psychiatr. 1995, 34:28-35.
42. Heim C., Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatr. 2001, 49:1023-1039.
43. Heim C., Newport D.J., Wagner D., Wilcox M.M., Miller A.H., Nemeroff C.B. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress. Anxiety 2002, 15:117-125.
44. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., Cullinanc W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front. Neuroendocrinol. 2003, 24:151-180.
45. Hughes C.W., Petty F., Shiekha S., Kramer G.L. Whole-blood serotonin in children and adolescents with mood and behavior disorders. Psychiat. Res. 1996, 65:79-95.
46. Ichise M., Vines D.C., Gura T., Anderson G.M., Suomi S.J., Higley J.D., Innis R.B. Effects of early stress on [11C] DABS positron emission tomography imaging of serotonin transportes in adolescent peer- and mother-reared rhesus monkeys. J. Neurosci. 2006, 26:4638-4643.
47. Kalivas P.W., Duffy P. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res. 1995, 675:325-328.
48. Kaufman J., Yang B.Z., Douglas-Palumberi H., Crouse-Artus M., Lipschitz D., Krystal J.H., Gelernter J. Genetic and environmental predictors of early alcohol use. Biol. Psychiatr. 2007, 61:1228-1234.
49. Kaufman J., Yang B.Z., Douglas-Palumberi H., Grasso D., Lipschitz D., Houshyar S., Krystal J.H., Gelernter J. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol. Psychiatr. 2006, 59:673-680.
50. Kendler K.S., Prescott C.A., Myers J., Neale M.C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Am. J. Psychiatr. 2003, 160:1549-1553.
51. Kirley A., Hawi Z., Daly G., Mccarron M., Mullins C., Millar N., Waldman I., Fitzgerald M., Gill M. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 2002, 27:607-619.
52. Koob G.F. The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res. 2010, 1314:3-14.
53. Kruesi M.J., Hibbs E.D., Zahn T.P., Keysor C.S., Hamburger S.D., Bartko J.J., Rapoport J.L. A 2-year prospective follow-up study of children and adolescents with disruptive behavior disorders. Prediction by cerebrospinal fluid 5-hydroxyindole-acetic acid, homovanillic acid, and autonomic measures?. Arch. Gen. Psychiat. 1992, 49:429-435.
54. Kruesi M.J., Rapoport J.L., Hamburger S., Hibbs E., Potter W.Z., Lenane M., Brown G.L. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch. Gen. Psychiat. 1990, 47:419-426.
55. Ladd C.O., Owens M.J., Nemeroff C.B. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology 1996, 137:1212-1218.
56. Luecken L.J., Appelhans B.M. Early parental loss and salivary cortisol in adulthood: the moderating role of family environment. Dev. Psychopathol. 2006, 18:295-308.
57. Luecken L.J., Kraft A., Hagan M.J. Negative relationships in the family-of-origin predict attenuated cortisol in emerging adults. Horm. Behav. 2009, 55:412-417.
58. Mcewen B.S. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000, 22:108-124.
59. Meaney M.J., Brake W., Gratton A. Environment regulation of the development of mesolimbic dopamine systems: a neurobiological mechanism for vulnerability to drug abuse?. Psychoneuroendocrinology 2002, 27:127-138.
60. Mihailescu S., Palomero-Rivero M., Meade-Huerta P., Maza-Flores A., Drucker-Colin R. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur. J. Pharmacol. 1998, 360:31-36.
61. Miller G.A., Keller J. Psychology and neuroscience: making peace. Curr. Dir. Psychol. Sci. 2000, 9:212-215.
62. Moffitt T.E., Brammer G.L., Caspi A., Fawcett J.P., Raleigh M., Yuwiler A., Silva P. Whole blood serotonin relates to violence in an epidemiological study. Biol. Psychiatr. 1998, 43:446-457.
63. Morgan D., Grant K.A., Gage H.D., Mach R.H., Kaplan J.R., Prioleau O., Nader S.H., Buchheimer N., Ehrenkaufer R.L., Nader M.A. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat. Neurosci. 2002, 5:169-174.
64. Mullen P.E., Martin J.L., Anderson J.C., Romans S.E., Herbison G.P. Childhood sexual abuse and mental health in adult life. Br. J. Psychiatr. 1993, 163:721-732.
65. Nagy O., Kelemen O., Benedek G., Myers C.E., Shohamy D., Gluck M.A., Keri S. Dopaminergic contribution to cognitive sequence learning. J. Neural Transm. 2007, 114:607-612.
66. Nederhof E., Bouma E.M., Oldehinkel A.J., Ormel J. Interaction between childhood adversity, brain-derived neurotrophic factor val/met and serotonin transporter promoter polymorphism on depression: the TRAILS study. Biol. Psychiatr. 2010, 68:209-212.
67. Nicolson N.A. Childhood parental loss and cortisol levels in adult men. Psychoneuroendocrinology 2004, 29:1012-1018.
68. Nightingale J., Williams R.M. Attitudes to emotional expression and personality in predicting post-traumatic stress disorder. Br. J. Clin. Psychol. 2000, 39(Pt 3):243-254.
69. Nilsson K.W., Sjöberg R.L., Damberg M., Alm P.O., Ohrvik J., Leppert J., Lindström L., Oreland L. Role of the serotonin transporter gene and family function in adolescent alcohol consumption. Alcohol Clin. Exp. Res. 2005, 29:564-570.
70. Osofsky J.D. The impact of violence in children. Future Child 1999, 9:33-49.
71. Oswald L.M., Wong D.F., Mccaul M., Zhou Y., Kuwabara H., Choi L., Brasic J., Wand G.S. Neuropsychopharmacology 2005, 30(4):821-832.
72. Oswald L.M., Wong D.F., Zhou Y., Kumar A., Brasic J., Alexander M., Ye W., Kuwabara H., Hilton J., Wand G.S. Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage 2007, 36:153-166.
73. Pacak K., Tjurmina O., Palkovits M., Goldstein D.S., Koch C.A., Hoff T., Chrousos G.P. Chronic hypercortisolemia inhibits dopamine synthesis and turnover in the nucleus accumbens: an in vivo microdialysis study. Neuroendocrinology 2002, 76:148-157.
74. Patkar A.A., Gopalakrishnan R., Berrettini W.H., Weinstein S.P., Vergare M.J., Leone F.T. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers. Psychopharmacology (Berlin) 2003, 166:221-227.
75. Pfeffer C.R., Altemus M., Heo M., Jiang H. Salivary cortisol and psychopathology in children bereaved by the September 11, 2001 terror attacks. Biol. Psychiatr. 2007, 61:957-965.
76. Poikolainen K. Antecedents of substance use in adolescence. Curr. Opin. Psychiatr. 2002, 3:241-245.
77. Rector N.A., Hood K., Richter M.A., Bagby R.M. Obsessive-compulsive disorder and the five-factor model of personality: distinction and overlap with major depressive disorder. Behav. Res. Ther. 2002, 40:1205-1219.
78. Ribeiro E.B., Bettiker R.L., Bogdanov M., Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 1993, 621:311-318.
79. Rogeness G.A., Hernandez J.M., Macedo C.A., Mitchell E.L. Biochemical differences in children with conduct disorder socialized and undersocialized. Am. J. Psychiat. 1982, 139:307-311.
80. Ross S., Peselow E. The neurobiology of addictive disorders. Clin. Neuropharm. 2009, 32:269-276.
81. Roy A., Hu X.Z., Janal M.N., Goldman D. Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology 2007, 32:2046-2052.
82. Sanchez M.M. The impact of early adverse care on HPA axis development: nonhuman primate models. Horm. Behav. 2006, 50:623-631.
83. Saxon A.J., Oreskovich M.R., Brkanac Z. Genetics determinants of addiction to opioids and cocaine. Harv. Rev. Psychiatr. 2005, 13:218-232.
84. Shea A., Walsh C., Macmillan H., Steiner M. Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females. Psychoneuroendocrinology 2005, 30:162-178.
85. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann. N. Y. Acad. Sci. 2008, 1141:105-130.
86. Spoont M.R. Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol. Bull. 1992, 112:330-350.
87. Steiger H., Richardson J., Joober R., Israel M., Bruce K.R., Ng Ying Kin N.M., Howard H., Anestin A., Dandurand C., Gauvin L. Dissocial behavior, the 5HTTLPR polymorphism, and maltreatment in women with bulimic syndromes. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B:128-130.
88. Stoltenberg S.F., Twitchell G.R., Hanna G.L., Cook E.H., Fitzgerald H.E., Zucker R.A., Little K.Y. Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. Am. J. Med. Genet. 2002, 114:230-234.
89. Sumiyoshi T., Kurachi M., Kurokawa K., Yotsutsuji T., Uehara T., Itoh H., Saitoh O. Plasma homovanillic acid in the prodromal phase of schizophrenia. Biol. Psychiatr. 2000, 47:428-433.
90. Teicher M.H., Andersen S.L., Polcari A., Anderson C.M., Navalta C.P. Developmental neurobiology of childhood stress and trauma. Psychiatr. Clin. North Am. 2002, 25:397-426.
91. Tiihonen J., Kuikka J.T., Bergstrom K.A., Karhu J., Viinamaki H., Lehtonen J., Hallikainen T., Yang J., Hakola P. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. Eur. J. Nucl. Med. 1997, 24:1253-1260.
92. Twitchell G.R., Hanna G.L., Cook E.H., Stoltenberg S.F., Fitzgerald H.E., Zucker R.A. Serotonin transporter promoter polymorphism genotype is associated with behavioral disinhibition and negative affect in children of alcoholics. Alcohol Clin. Exp. Res. 2001, 25:953-959.
93. Tyrka A.R., Wier L., Price L.H., Ross N., Anderson G.M., Wilkinson C.W., Carpenter L.L. Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biol. Psychiat. 2008, 63:1147-1154.
94. Ueno S., Nakamura M., Mikami M., Kondoh K., Ishiguro H., Arinami T., Komiyama T., Mitsushio H., Sano A., Tanabe H. Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism. Mol. Psychiatr. 1999, 4:552-557.
95. Unis A.S., Cook E.H., Vincent J.G., Gjerde D.K., Perry B.D., Mason C., Mitchell J. Platelet serotonin measures in adolescents with conduct disorder. Biol. Psychiat. 1997, 42:553-559.
96. Van der kolk B.A., Perry J.C., Herman J.L. Childhood origins of self-destructive behavior. Am. J. Psychiatr. 1991, 148:1665-1671.
97. van Goozen S.H.M., Fairchild G. Neuroendocrine and neurotransmitter correlates in children with antisocial behaviour. Horm. Behav. 2006, 50:647-654.
98. Vandenbergh D.J., Bennett C.J., Grant M.D., Strasser A.A., O'Connor R., Stauffer R.L., Vogler G.P., Kozlowski L.T. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different. Nicotine Tob. Res. 2002, 4:247-249.
99. Virkkunen M., Linnoila M. Serotonin in early onset, male alcoholics with violent behaviour. Ann. Med. 1990, 22:327-331.
100. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex 2000, 10:318-325.
101. Wernicke C., Smolka M., Gallinat J., Winterer G., Schmidt L.G., Rommelspacher H. Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population. Neurosci. Lett. 2002, 333:45-48.
102. Widom C.S., Marmorstein N.R., White H.R. Childhood victimization and illicit drug use in middle adulthood. Psychol. Addict. Behav. 2006, 20:394-403.
103. Wills T.A., Vaccaro D., McNamara G., Hirky A.E. Escalated substance use: a longitudinal grouping analysis from early to middle adolescence. J. Abnorm. Psychol. 1996, 105:166-180.
104. Young S.E., Smolen A., Corley R.P., Krauter K.S., DeFries J.C., Crowley T.J., Hewitt J.K. Dopamine transporter polymorphism associated with externalizing behavior problems in children. Am. J. Med. Genet. 2002, 114:144-149.